Nothing Special   »   [go: up one dir, main page]
create a website
Incentives for clinical trials. (2009). Grönqvist, Erik ; Lundin, Douglas ; Gronqvist, Erik.
In: Economics of Innovation and New Technology.
RePEc:taf:ecinnt:v:18:y:2009:i:5:p:513-531.

Full description at Econpapers || Download paper

Cited: 0

Citations received by this document

Cites: 16

References cited by this document

Cocites: 50

Documents which have cited the same bibliography

Coauthors: 0

Authors who have wrote about the same topic

Citations

Citations received by this document

    This document has not been cited yet.

References

References cited by this document

  1. Angell M., 2004. The truth about the drug industry: How they deceive us and what to do about it
    Paper not yet in RePEc: Add citation now

  2. Azoulay, Pierre. (2002). Do Pharmaceutical Sales Respond to Scientific Evidence?. In:, 11 4 pp. 551-594.

  3. Bester, Helmut. (1998). Quality Uncertainty Mitigates Product Differentiation. In: The RAND Journal of Economics, 29 4 pp. 828.

  4. DiMasi, Joseph A ; Hansen, Ronald W ; Grabowski, Henry G. (2003). The price of innovation: new estimates of drug development costs. In: Journal of Health Economics, 22 2 pp. 151-185.

  5. Ekelund, Mats ; Persson, Björn. (2003). Pharmaceutical Pricing in a Regulated Market. In: Review of Economics and Statistics, 85 2 pp. 298-306.

  6. Heres, Stephan ; Davis, John ; Maino, Katja ; Jetzinger, Elisabeth ; Kissling, Werner ; Leucht, Stefan. (2006). Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics. In: AJP, 163 2 pp. 185-194.
    Paper not yet in RePEc: Add citation now

  7. Jaskold Gabszewicz, J ; Thisse, J.-F. (1979). Price competition, quality and income disparities. In: Journal of Economic Theory, 20 3 pp. 340-359.

  8. Jaskold Gabszewicz, J ; Thisse, J.-F. (1980). Entry (and exit) in a differentiated industry. In: Journal of Economic Theory, 22 2 pp. 327-338.

  9. Lexchin, J.. (2003). Pharmaceutical industry sponsorship and research outcome and quality: systematic review. In:, 326 7400 pp. 1167-1170.
    Paper not yet in RePEc: Add citation now

  10. Lu, Z. John ; Comanor, William S.. (1998). Strategic Pricing of New Pharmaceuticals. In: Review of Economics and Statistics, 80 1 pp. 108-118.

  11. Melander, H.. (2003). Evidence b(i)ased medicine--selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. In:, 326 7400 pp. 1171-1173.
    Paper not yet in RePEc: Add citation now

  12. Riordan, Michael H.. (1986). Monopolistic Competition with Experience Goods. In: The Quarterly Journal of Economics, 101 2 pp. 265.

  13. Rogerson, William P.. (1988). Price Advertising and the Deterioration of Product Quality. In: The Review of Economic Studies, 55 2 pp. 215.

  14. Shaked, Avner ; Sutton, John. (1982). Relaxing Price Competition Through Product Differentiation. In: The Review of Economic Studies, 49 1 pp. 3.

  15. Tirole J., 1988. The theory of industrial organization

  16. Wolinsky, Asher. (1983). Prices as Signals of Product Quality. In: The Review of Economic Studies, 50 4 pp. 647.

Cocites

Documents in RePEc which have cited the same bibliography

  1. Do Firms Publish? A Multi-Sectoral Analysis. (2018). Rotolo, Daniele ; Grassano, Nicola ; Camerani, Roberto.
    In: SPRU Working Paper Series.
    RePEc:sru:ssewps:2018-21.

    Full description at Econpapers || Download paper

  2. Do firms publish? A multi-sectoral analysis. (2018). Rotolo, Daniele ; Grassano, Nicola ; Camerani, Roberto.
    In: JRC Working Papers on Corporate R&D and Innovation.
    RePEc:ipt:wpaper:201805.

    Full description at Econpapers || Download paper

  3. Knowledge dissemination in clinical trials: Exploring influences of institutional support and type of innovation on selective reporting. (2018). Salandra, Rossella.
    In: Research Policy.
    RePEc:eee:respol:v:47:y:2018:i:7:p:1215-1228.

    Full description at Econpapers || Download paper

  4. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiutil:be3f3c38-5e39-4a67-af57-820c14957e0b.

    Full description at Econpapers || Download paper

  5. Umbrella Branding in Pharmaceutical Markets. (2017). Suppliet, Moritz.
    In: Discussion Paper.
    RePEc:tiu:tiucen:6ee607fc-8602-4270-a076-3b0a18f71366.

    Full description at Econpapers || Download paper

  6. How does the partner type in R&D alliances impact technological innovation performance? A study on the Korean biotechnology industry. (2016). Park, Gunno ; Ji, Sang ; Shin, Kwangsoo.
    In: Asia Pacific Journal of Management.
    RePEc:kap:asiapa:v:33:y:2016:i:1:d:10.1007_s10490-015-9439-7.

    Full description at Econpapers || Download paper

  7. Corporate Science, Innovation, and Firm Value. (2016). Cincera, Michele ; Simeth, Markus .
    In: Management Science.
    RePEc:inm:ormnsc:v:62:y:2016:i:7:p:1970-1981.

    Full description at Econpapers || Download paper

  8. Brand Performance Volatility from Marketing Spending. (2016). Shin, Hyun Song ; Fischer, Marc ; Hanssens, Dominique M.
    In: Management Science.
    RePEc:inm:ormnsc:v:62:y:2016:i:1:p:197-215.

    Full description at Econpapers || Download paper

  9. The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs. (2016). Horstmann, Ignatius ; Clark, Robert ; Ching, Andrew ; Lim, Hyunwoo.
    In: Marketing Science.
    RePEc:inm:ormksc:v:35:y:2016:i:1:p:158-181.

    Full description at Econpapers || Download paper

  10. Killing the Golden Goose? The Decline of Science in Corporate R&D. (2015). Belenzon, Sharon ; Arora, Ashish ; Patacconi, Andrea.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:20902.

    Full description at Econpapers || Download paper

  11. How do firms develop capabilities for scientific disclosure?. (2015). Lhuillery, Stephane ; Simeth, Markus .
    In: Research Policy.
    RePEc:eee:respol:v:44:y:2015:i:7:p:1283-1295.

    Full description at Econpapers || Download paper

  12. The Regulation of Direct-to-Consumer Advertising of Pharmaceuticals in a Managed Care Setting. (2015). Ryan, Matthew ; Vaithianathan, Rhema .
    In: Journal of Public Economic Theory.
    RePEc:bla:jpbect:v:17:y:2015:i:6:p:986-1021.

    Full description at Econpapers || Download paper

  13. The commercial contribution of clinical studies for pharmaceutical drugs. (2014). Sood, Ashish ; Stremersch, Stefan ; Kappe, Eelco.
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:31:y:2014:i:1:p:65-77.

    Full description at Econpapers || Download paper

  14. Information technology and agency in physicians prescribing decisions. (2014). Epstein, Andrew J. ; Ketcham, Jonathan D..
    In: RAND Journal of Economics.
    RePEc:bla:randje:v:45:y:2014:i:2:p:422-448.

    Full description at Econpapers || Download paper

  15. Pharmaceutical Followers. (2013). Ridley, David ; Ellickson, Paul ; Landry, Peter ; Arcidiacono, Peter .
    In: NBER Working Papers.
    RePEc:nbr:nberwo:19522.

    Full description at Econpapers || Download paper

  16. What is the value of ‘me-too’ drugs?. (2013). Regnier, Stephane .
    In: Health Care Management Science.
    RePEc:kap:hcarem:v:16:y:2013:i:4:p:300-313.

    Full description at Econpapers || Download paper

  17. Pharmaceutical advertising and Medicare Part D. (2013). Sood, Neeraj ; Lakdawalla, Darius ; Gu, Qian .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:6:p:1356-1367.

    Full description at Econpapers || Download paper

  18. Competition in the pharmaceutical industry: How do quality differences shape advertising strategies?. (2013). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles .
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:32:y:2013:i:1:p:268-285.

    Full description at Econpapers || Download paper

  19. Drug withdrawals and the utilization of therapeutic substitutes: The case of Vioxx. (2013). Simon, Kosali I. ; Tennyson, Sharon ; Collins, Michael J..
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:86:y:2013:i:c:p:148-168.

    Full description at Econpapers || Download paper

  20. Pharmaceutical followers. (2013). Ridley, David ; Landry, Peter ; Arcidiacono, Peter ; Ellickson, Paul B..
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:5:p:538-553.

    Full description at Econpapers || Download paper

  21. Informing the uninformed: How drug advertising affects check-up visits. (2013). Wendling, Brett ; Hosken, Daniel .
    In: International Journal of Industrial Organization.
    RePEc:eee:indorg:v:31:y:2013:i:2:p:181-194.

    Full description at Econpapers || Download paper

  22. The impact of scientific research on health care: Evidence from the OECD countries. (2013). Moscone, Francesco ; Tosetti, Elisa ; Costantini, Marco ; Ali, Maged .
    In: Economic Modelling.
    RePEc:eee:ecmode:v:32:y:2013:i:c:p:325-332.

    Full description at Econpapers || Download paper

  23. Pricing dynamics and product quality: the case of antidepressant drugs. (2012). Rizzo, John ; Chen, Jie.
    In: Empirical Economics.
    RePEc:spr:empeco:v:42:y:2012:i:1:p:279-300.

    Full description at Econpapers || Download paper

  24. Physician response to financial incentives when choosing drugs to treat breast cancer. (2012). Johnson, Scott ; Epstein, Andrew .
    In: International Journal of Health Economics and Management.
    RePEc:kap:ijhcfe:v:12:y:2012:i:4:p:285-302.

    Full description at Econpapers || Download paper

  25. Getting Competition Down to a Science: The Effects of Technological Competition on Firms Scientific Publications. (2012). Polidoro, Francisco ; Theeke, Matt .
    In: Organization Science.
    RePEc:inm:ororsc:v:23:y:2012:i:4:p:1135-1153.

    Full description at Econpapers || Download paper

  26. The impact of direct-to-consumer advertising of prescription drugs on physician visits and drug requests: Empirical findings and public policy implications. (2011). Liu, Qiang ; Gupta, Sachin.
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:28:y:2011:i:3:p:205-217.

    Full description at Econpapers || Download paper

  27. Does Patient Use of Medical Information Affect Physician Practice Incentives to Provide Care?. (2011). Rizzo, John ; Fang, Hai .
    In: Forum for Health Economics & Policy.
    RePEc:bpj:fhecpo:v:14:y:2011:i:2:n:2.

    Full description at Econpapers || Download paper

  28. The effects of detailing on prescribing decisions under quality uncertainty. (2010). Ching, Andrew ; Ishihara, Masakazu.
    In: Quantitative Marketing and Economics (QME).
    RePEc:kap:qmktec:v:8:y:2010:i:2:p:123-165.

    Full description at Econpapers || Download paper

  29. Deviation Among Technology Reviews: An Informative Enrichment of Technology Evolution Theory for Marketing. (2010). Stremersch, Stefan ; Sood, A..
    In: ERIM Report Series Research in Management.
    RePEc:ems:eureri:17766.

    Full description at Econpapers || Download paper

  30. Competition in the Pharmaceutical Industry: How do Quality Differences Shape Advertising Strategies?. (2010). Siotis, Georges ; Ornaghi, Carmine ; de Frutos, Maria-Angeles.
    In: CEPR Discussion Papers.
    RePEc:cpr:ceprdp:8076.

    Full description at Econpapers || Download paper

  31. Incentives for clinical trials. (2009). Grönqvist, Erik ; Lundin, Douglas ; Gronqvist, Erik.
    In: Economics of Innovation and New Technology.
    RePEc:taf:ecinnt:v:18:y:2009:i:5:p:513-531.

    Full description at Econpapers || Download paper

  32. Information, learning, and drug diffusion: The case of Cox-2 inhibitors. (2009). Chintagunta, Pradeep ; Jiang, Renna ; Jin, Ginger.
    In: Quantitative Marketing and Economics (QME).
    RePEc:kap:qmktec:v:7:y:2009:i:4:p:399-443.

    Full description at Econpapers || Download paper

  33. Knowledge and information flows in supply chains: A study on pharmaceutical companies. (2009). Nakano, Davi ; Pedroso, Marcelo Caldeira .
    In: International Journal of Production Economics.
    RePEc:eee:proeco:v:122:y:2009:i:1:p:376-384.

    Full description at Econpapers || Download paper

  34. Patient education and the impact of new medical research. (2009). Simon, Kosali ; Price, Joseph.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1166-1174.

    Full description at Econpapers || Download paper

  35. Trials, tricks and transparency: How disclosure rules affect clinical knowledge. (2009). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:28:y:2009:i:6:p:1141-1153.

    Full description at Econpapers || Download paper

  36. Trials, tricks and transparency: how disclosure rules affect clinical knowledge. (2008). González, Paula ; Dahm, Matthias ; Gonzalez, Paula ; Fresco, Nicolas Porteiro .
    In: Working Papers.
    RePEc:urv:wpaper:2072/5360.

    Full description at Econpapers || Download paper

  37. Trials, Tricks and Transparency: How Disclosure Rules Affect Clinical Knowledge. (2008). Porteiro, Nicolás ; González, Paula ; Dahm, Matthias ; Gonzalez, Paula.
    In: Working Papers.
    RePEc:pab:wpaper:08.02.

    Full description at Econpapers || Download paper

  38. Generalizations on the effectiveness of pharmaceutical promotional expenditures. (2008). , Sara ; Wieringa, Jaap E ; PEter, .
    In: International Journal of Research in Marketing.
    RePEc:eee:ijrema:v:25:y:2008:i:4:p:234-246.

    Full description at Econpapers || Download paper

  39. The Effects of Detailing on Prescribing Decisions under Two-Sided Learning. (2007). Ching, Andrew ; Ishihara, Masakazu.
    In: MPRA Paper.
    RePEc:pra:mprapa:4935.

    Full description at Econpapers || Download paper

  40. The Debate on Influencing Doctors Decisions: Are Drug Characteristics the Missing Link?. (2007). Venkataraman, Sriram ; Stremersch, Stefan .
    In: Management Science.
    RePEc:inm:ormnsc:v:53:y:2007:i:11:p:1688-1701.

    Full description at Econpapers || Download paper

  41. The Debate on Influencing Doctors’ Decisions: Are Drug Characteristics the Missing Link?. (2007). Stremersch, Stefan ; Venkataraman, S..
    In: ERIM Report Series Research in Management.
    RePEc:ems:eureri:10520.

    Full description at Econpapers || Download paper

  42. Incentives for Clinical Trials. (2006). Grönqvist, Erik ; Lundin, Douglas ; Gronqvist, Erik.
    In: SSE/EFI Working Paper Series in Economics and Finance.
    RePEc:hhs:hastef:0636.

    Full description at Econpapers || Download paper

  43. Direct to consumer advertising in pharmaceutical markets. (2006). Kuhn, Michael ; Brekke, Kurt.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:25:y:2006:i:1:p:102-130.

    Full description at Econpapers || Download paper

  44. The economics of follow-on drug research and development: Trends in entry rates and the timing of development — The authors’ reply. (2005). DiMasi, Joseph ; Paquette, Cherie .
    In: PharmacoEconomics.
    RePEc:spr:pharme:v:23:y:2005:i:12:p:1193-1202.

    Full description at Econpapers || Download paper

  45. The Competitive Effects of Drug Withdrawals. (2005). Rizzo, John ; Cawley, John.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:11223.

    Full description at Econpapers || Download paper

  46. Direct to Consumer Advertising in Pharmaceutical Markets. (2005). Kuhn, Michael ; Brekke, Kurt.
    In: CESifo Working Paper Series.
    RePEc:ces:ceswps:_1493.

    Full description at Econpapers || Download paper

  47. Are Physicians ÜEasy MarksÝ? Quantifying the Effects of Detailing and Sampling on New Prescriptions. (2004). Mizik, Natalie ; Jacobson, Robert .
    In: Management Science.
    RePEc:inm:ormnsc:v:50:y:2004:i:12:p:1704-1715.

    Full description at Econpapers || Download paper

  48. An empirical model of learning and patient spillovers in new drug entry. (2004). Shum, Matthew ; Coscelli, Andrea .
    In: Journal of Econometrics.
    RePEc:eee:econom:v:122:y:2004:i:2:p:213-246.

    Full description at Econpapers || Download paper

  49. Direct-to-Consumer Advertising and the Demand for Cholesterol-Reducing Drugs. (2002). Winston, Clifford ; Stempski, Randolph ; Calfee, John E..
    In: Journal of Law and Economics.
    RePEc:ucp:jlawec:doi:10.1086/374704.

    Full description at Econpapers || Download paper

  50. Dynamic R&D and the Effectiveness of Policy Intervention in the Pharmaceutical Industry. (). Kryukov, Yaroslav .
    In: GSIA Working Papers.
    RePEc:cmu:gsiawp:-1122776787.

    Full description at Econpapers || Download paper

Coauthors

Authors registered in RePEc who have wrote about the same topic

Report date: 2025-02-08 08:41:19 || Missing content? Let us know

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2023. Contact: CitEc Team.